South Brisbane, QUEENSLAND2 Active Studies

Crohns Disease Clinical Trials in South Brisbane, QUEENSLAND

Find 2 actively recruiting crohns disease clinical trials in South Brisbane, QUEENSLAND. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
416
Enrolling

Recruiting Crohns Disease Studies in South Brisbane

About Crohns Disease Clinical Trials in South Brisbane

Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 2 crohns disease clinical trials recruiting participants in South Brisbane, QUEENSLAND. These studies are seeking a combined 416 participants. Research is being sponsored by Alimentiv Inc., Janssen-Cilag Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Crohns Disease Clinical Trials in South Brisbane — FAQ

Are there crohns disease clinical trials in South Brisbane?

Yes, there are 2 crohns disease clinical trials currently recruiting in South Brisbane, QUEENSLAND. Browse the studies on this page to find one that fits.

How do I join a clinical trial in South Brisbane?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the South Brisbane research site will contact you about next steps.

Are clinical trials in South Brisbane free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many South Brisbane studies also compensate for your time and travel.

What crohns disease treatments are being tested?

The 2 active trials in South Brisbane are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.

Data updated March 2, 2026 from ClinicalTrials.gov